Article

Glaucoma implant gets FDA OK for more tests

Fort Lauderdale, FL-The FDA has given GMP Companies Inc. its approval to expand a phase III clinical trial of its Eyepass glaucoma implant.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
© 2025 MJH Life Sciences

All rights reserved.